T1	Outcomes 15 23	efficacy
T2	Outcomes 28 34	safety
T3	Outcomes 223 231	efficacy
T4	Outcomes 236 242	safety
T5	Outcomes 627 668	percent improvement of the RP attack rate
T6	Outcomes 880 902	serious adverse events
T7	Outcomes 917 948	almost adverse events were mild
T8	Outcomes 1013 1022	effective
T9	Outcomes 1114 1123	tolerable
